Table 3.
Baseline characteristics and AMI + SCAD—control risk factors in the study population.
| Full Population | Propensity-Score-Matched Population | |||||
|---|---|---|---|---|---|---|
| AMI + SCAD Patients (N = 1955) | Controls (N = 2288) | p | AMI + SCAD Patients (N = 1397) | Controls (N = 1397) | p | |
| Age (years) | 66.00(58.00,75.00) | 56.00(47.00,66.00) | <0.001 | 63.00(55.00,70.00) | 63.00(55.00,70.00) | 0.982 |
| Gender | <0.001 | 0.849 | ||||
| Male (%) | 1086(55.50%) | 1124(49.10%) | 751(53.80%) | 756(54.10%) | ||
| Female (%) | 869(44.50%) | 1164(50.90%) | 646(46.20%) | 641(45.90%) | ||
| Smokers (Yes/No) | 841/1114 | 736/1552 | <0.001 | 562/835 | 544/853 | 0.486 |
| Hypertension (Yes/No) | 993/962 | 994/1294 | <0.001 | 686/711 | 667/730 | 0.472 |
| Diabetes (Yes/No) | 406/1549 | 166/2122 | <0.001 | 169/1228 | 162/1235 | 0.682 |
| TG (mmol/L) | 1.44(1.05,2.07) | 1.35(0.96,2.02) | <0.001 | 1.43(1.03,2.08) | 1.41(1.01,2.07) | 0.326 |
| Tc (mmol/L) | 4.64(3.91,5.41) | 4.58(3.91,5.31) | 0.246 | 4.69(3.95,5.42) | 4.64(3.94,5.40) | 0.792 |
| HDL (mmol/L) | 1.06(0.90,1.26) | 1.12(0.95,1.33) | <0.001 | 1.09(0.92,1.29) | 1.09(0.92,1.30) | 0.724 |
| LDL (mmol/L) | 3.05(2.47,3.68) | 2.97(2.42,3.57) | 0.005 | 3.07(2.48,3.68) | 3.05(2.51,3.69) | 0.978 |